These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29109373)

  • 1. Development of a Lethal Intranasal Exposure Model of Ebola Virus in the Cynomolgus Macaque.
    Alfson KJ; Avena LE; Worwa G; Carrion R; Griffiths A
    Viruses; 2017 Oct; 9(11):. PubMed ID: 29109373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Ebola Virus Mucosal Challenge Routes in Cynomolgus Macaques.
    Johnson DM; Brasel T; Massey S; Smith J; Garron T; Wallace S; Yu X; Beasley DW; Comer JE
    J Virol; 2023 May; 97(5):e0188822. PubMed ID: 36975793
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed Disease in Cynomolgus Macaques Exposed to Ebola Virus by an Intranasal Route.
    Johnston SC; Wilhelmsen CL; Shamblin J; Kimmel A; Zelko J; Wollen S; Goff AJ
    Front Immunol; 2021; 12():709772. PubMed ID: 34484210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.
    Alfson KJ; Avena LE; Beadles MW; Staples H; Nunneley JW; Ticer A; Dick EJ; Owston MA; Reed C; Patterson JL; Carrion R; Griffiths A
    J Virol; 2015 Jul; 89(13):6773-81. PubMed ID: 25903348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever.
    Speranza E; Bixler SL; Altamura LA; Arnold CE; Pratt WD; Taylor-Howell C; Burrows C; Aguilar W; Rossi F; Shamblin JD; Wollen SE; Zelko JM; Minogue T; Nagle E; Palacios G; Goff AJ; Connor JH
    Sci Transl Med; 2018 Mar; 10(434):. PubMed ID: 29593102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals.
    Wong G; Richardson JS; Cutts T; Qiu X; Kobinger GP
    Antiviral Res; 2015 Apr; 116():17-9. PubMed ID: 25596432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.
    Dowall SD; Jacquot F; Landon J; Rayner E; Hall G; Carbonnelle C; Raoul H; Pannetier D; Cameron I; Coxon R; Al Abdulla I; Hewson R; Carroll MW
    Sci Rep; 2017 Jun; 7(1):4099. PubMed ID: 28642489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
    Bratcher A; Hoff NA; Doshi RH; Gadoth A; Halbrook M; Mukadi P; Musene K; Ilunga-Kebela B; Spencer D; Bramble MS; McIlwan D; Kelly JD; Mukadi D; Kingebeni PM; Ahuka S; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009566. PubMed ID: 34383755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
    Su QD; He SH; Yi Y; Qiu F; Lu XX; Jia ZY; Meng QL; Fan XT; Tian RG; Audet J; Qiu XG; Bi SL
    Vaccine; 2018 Oct; 36(41):6053-6060. PubMed ID: 30195490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.
    Bornholdt ZA; Herbert AS; Mire CE; He S; Cross RW; Wec AZ; Abelson DM; Geisbert JB; James RM; Rahim MN; Zhu W; Borisevich V; Banadyga L; Gunn BM; Agans KN; Wirchnianski AS; Goodwin E; Tierney K; Shestowsky WS; Bohorov O; Bohorova N; Velasco J; Ailor E; Kim D; Pauly MH; Whaley KJ; Alter G; Walker LM; Chandran K; Zeitlin L; Qiu X; Geisbert TW; Dye JM
    Cell Host Microbe; 2019 Jan; 25(1):49-58.e5. PubMed ID: 30629918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop.
    Banadyga L; Zhu W; Kailasan S; Howell KA; Franaszek K; He S; Siragam V; Cheng K; Yan F; Moffat E; Cao W; Leung A; Embury-Hyatt C; Aman MJ; Qiu X
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
    Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
    Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
    Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
    mBio; 2019 May; 10(3):. PubMed ID: 31138743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 16. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.
    Pinski A; Woolsey C; Jankeel A; Cross R; Basler CF; Geisbert T; Messaoudi I
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
    Wong G; Richardson JS; Pillet S; Racine T; Patel A; Soule G; Ennis J; Turner J; Qiu X; Kobinger GP
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S379-83. PubMed ID: 25957963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus.
    Mire CE; Geisbert JB; Agans KN; Deer DJ; Fenton KA; Geisbert TW
    J Infect Dis; 2016 Oct; 214(suppl 3):S263-S267. PubMed ID: 27284090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Respiratory Infection of Marmosets (Callithrix jacchus) With Ebola Virus Kikwit.
    Smither SJ; Nelson M; Eastaugh L; Nunez A; Salguero FJ; Lever MS
    J Infect Dis; 2015 Oct; 212 Suppl 2():S336-45. PubMed ID: 26209682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.